EMD Serono Science Award
Forecasted
The EMD Serono Science Award recognizes external scientists for completed preclinical healthcare research, celebrating scientific breakthroughs with the potential to make a difference for patients.
Funder: Merck KGaA (EMD Group)
Due Dates (Anticipated): December 2026 (Nomination deadline)
Funding Amounts: €30,000 honorarium; usually one winner per year
Summary: An annual award recognizing outstanding preclinical research accomplishments in healthcare.
Key Information: Healthcare Professionals are not eligible; winners must undertake award-related activities.
Description
The EMD Serono Science Award is an annual achievement award bestowed by the Healthcare Business of Merck KGaA, Darmstadt, Germany. Named in honor of pharmacist and researcher Johann Anton Merck, it recognizes globally renowned external scientists for preclinical accomplishments in areas of the company’s strategic healthcare focus. It celebrates research already accomplished rather than funding a proposed project.
The award is called the EMD Serono Science Award when presented in the United States or Canada; elsewhere, it is called the Johann Anton Merck Award. Nomination criteria emphasize research with potential to make a difference for patients, scientific quality and impact, and breakthroughs relevant to the company’s healthcare focus.
